A first-in-human, single-ascending dose trial of PRS-060 for the treatment of asthma
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs PRS 060 (Primary)
- Indications Asthma
- Focus Adverse reactions; First in man
- Sponsors Pieris Pharmaceuticals
- 09 Aug 2017 According to a Pieris Pharmaceuticals media release, this trial is planned to conduct under a clinical trial notification to the Therapeutic Goods Administration in Australia.
- 09 Aug 2017 According to a Pieris Pharmaceuticals media release, the company plans to dose healthy subjects in this trial in the fourth quarter of 2017.
- 27 Feb 2017 Planned initiation date changed from 1 Jan 2017 to 1 Jun 2017.